You are here

Coronary Intervention & Surgery

 

Hospitals ranked in the top 50 for cardiology and heart surgery by U.S. News and World Report appear no better at performing PCI than unranked hospitals, according to an analysis of more than 500,000 procedures performed at 654 hospitals.

PCI of chronic total occlusions (CTOs) can be safely performed by expert operators and provides significant benefit to patients with reduced left ventricular ejection fraction (LVEF) or diabetes, according to a series of studies published Nov. 13 in JACC: Cardiovascular Interventions.

Scaffold discontinuity, malapposition and neoatherosclerosis were found to be the leading mechanisms behind very late scaffold thrombosis (VLScT) in cardiac patients implanted with bioresorbable devices, investigators from the INVEST registry have reported.

Recent studies have shown robotic PCI to be a feasible way to treat coronary artery disease. But at the annual Transcatheter Cardiovascular Therapeutics (TCT) conference Oct. 30, Ryan D. Madder, MD, took the conversation a step further: Will it eventually be possible to perform “tele-stenting” over long distances?

Research presented Nov. 2 at the Transcatheter Cardiovascular Therapeutics scientific symposium in Denver demonstrates patients with stable coronary artery disease (CAD) and abnormal fractional flow reserve (FFR) derive better clinical outcomes with PCI at similar cost to medical therapy alone.

 

Recent Headlines

Planning for the Ideal Cath Lab Requires the Multidisciplinary Approach

Planning and creating the best cath lab for your facility and market requires a wide range of considerations, from current and future business patterns to space design to workflow and communication concerns. A good plan that includes input from all the relevant stakeholders goes a long way toward a successful long-term venture.

Roundtable Discussion: The Big 4 Stentmakers

Cardiovascular Business invited representatives from the four major stent manufacturers to discuss the challenges and future outlook for drug-eluting stents (DES).

Can Off-Hour D2B Times be Reduced Without Breaking the Bank

The persistent discrepancy between the door-to-balloon times of on-hours versus off-hours in STEMI patients undergoing PCI procedures can be solved through cost-effective means; however, some argue that an expensive and complex pre-activation program is needed to bring off-hour times in line with those of on-hours.

Cath Lab Exposé: What it takes to keep patients, profits, and referring docs in today's changing landscape

Cardiac cath labs operate in an increasingly challenging environment, contending with a variety of clinical, demographic, regulatory and competitive factors.

Wracked by Bad Press, Drug-Eluting Stents Start Their Comeback

The utilization of drug-eluting stents may be poised for a comeback based on recent clinical studies that found they have value despite some risks. Industry analysts, however, suggest that there their usage has plateaued and they can not maintain their initial groundbreaking sales. 

Coronary Intervention: Financial Factors Facing Cath Labs

Recent trial results, multidetector CT and new and more uses for the services and equipment of the traditional cardiac catheterization lab are impacting the bottom line of facilities across the country. These and more factors may have temporarily decreased cath lab procedures, but experts in the field predict recovery—albeit a changing face for the cath lab.

Strategies to Trim Door-to-Balloon Time

Door-to-balloon time (D2B) is a critical cardiac quality indicator. As a whole, U.S. hospitals are doing fairly well with other quality indicators, says Betsy Bradley, PhD, professor of public health at Yale University in New Haven, Conn., but D2B time is a challenge for many sites. Here are some prescriptions to break the 90-minute barrier.

The Cardiac Cath Lab in Evolution

Cardiac catheterization labs across the country are evolving. Changes in types and volumes of procedures combined with an increasingly competitive environment and reimbursement cuts are forcing cath labs to adapt and fine-tune their management strategies. What brings success? Diversifying into EP and peripheral vascular procedures, tightly managing and even consigning pricey inventory such as drug-eluting stents, cross-training staff, and ensuring high flexibility.

Pages